v3.25.1
Defined Benefit Plan
12 Months Ended
Dec. 31, 2024
Defined Benefit Plan [Abstract]  
Defined Benefit Plan

Note 14 — Defined Benefit Plan

 

Proteomedix sponsors a defined benefit pension plan (the “Swiss Plan”) covering certain eligible employees. The Swiss Plan provides retirement benefits based on years of service and compensation levels.

 

The following significant actuarial assumptions were used in calculating the benefit obligation and the net periodic benefit cost as of December 31, 2024 and 2023:

 

   December 31,
2024
   December 31,
2023
 
Discount rate   1.00%   1.45%
           
Expected long-term rate of return on plan assets    1.00%    1.45%
Rate of compensation increase   1.50%   3.00%

 

Changes in these assumptions may have a material impact on the plan’s obligations and costs.

 

The components of net periodic benefit cost for the year ended December 31, 2024 and for the period from December 15, 2023 to December 31, 2023 are as follows:

 

   For the year ended
December 31,
2024
  

For the period

December 15,
2023
through December 31,
2023

 
Service cost  $            97,964   $              4,278 
Interest cost   30,032    1,943 
Expected return on plan assets   (23,343)   (1,581)
Amortization of net (gain) loss   (15,346)   (1,534)
Settlements (gain) loss   
-
    (1,157)
Total  $89,307   $1,949 

 

During the year ended December 31, 2024 and for the period ended December 15, 2023 through December 31, 2023, the Company made pension contributions of approximately $89,404 and $0, respectively.

The components of accumulated comprehensive loss attributable to the Company’s pension plan for the year ended December 31, 2024 and for the period from December 15, 2023 to December 31, 2023 are as follows: 

 

   For the year ended December 31,
2024
   For the period
December 15,
2023
through
December 31,
2023
 
Net loss (gain)  $         (190,064)  $               7,277 
Prior service cost (credit)   (63,292)   
-
 
Amortization of net gain   15,346    1,534 
Effect of settlement   
-
    1,157 
Other adjustments   
-
    (4,005)
Total recorded during the period  $(238,010)  $5,963 

 

As of December 31, 2024 and 2023, the funded status of the plan and the amounts recognized in the accompanying consolidated balance sheet are as follows:

 

   December 31, 
   2024   2023 
Projected benefit obligation  $2,593,360   $2,299,970 
Fair value of plan assets   2,312,481    1,743,674 
Overfunded (underfunded) status  $(280,879)  $(556,296)

 

A reconciliation of the beginning and ending balances of the accumulated benefit obligation is provided in the table below:

 

As of December 31, 2023  $2,299,970 
Service cost   97,964 
Interest cost   30,032 
Actuarial (gain) loss   72,031 
Benefits paid   (20,824)
Ordinary contributions paid by employees   89,404 
Contributions paid by plan participants   125,553 
Plan amendments   (100,770)
Projected benefit obligation as of December 31, 2024   2,593,360 
Actuarial (gain)/loss due to assumption changes   (37,727)
Actuarial (gain)/loss due to plan experience   109,758 
Accumulated benefit obligation as of December 31, 2024  $2,665,391 

 

A reconciliation of the beginning and ending balances of the plan assets is provided in the table below:

 

As of December 31, 2023  $1,743,674 
Actual return on plan assets   285,270 
Contributions paid by employer   89,404 
Ordinary contributions paid by employees   89,404 
Contributions paid by plan participants   125,553 
Benefits paid   (20,824)
Settlements   
-
 
As of December 31, 2024  $2,312,481 

Projected benefit payments for the next five years as of December 31, 2024 are as follows:

 

Years ending December 31,
2025  $113,000 
2026   111,000 
2027   108,000 
2028   106,000 
2029   104,000 
Thereafter   464,000 
Total  $1,006,000